Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X

Users Online : 53589

AbstractMaterial and MethodsResultsDiscussionConclusionAcknowledgementReferencesDOI and Others
Article in PDF How to Cite Citation Manager Readers' Comments (0) Audio Visual Article Statistics Link to PUBMED Print this Article Send to a Friend
Advertisers Access Statistics Resources

Dr Mohan Z Mani

"Thank you very much for having published my article in record time.I would like to compliment you and your entire staff for your promptness, courtesy, and willingness to be customer friendly, which is quite unusual.I was given your reference by a colleague in pathology,and was able to directly phone your editorial office for clarifications.I would particularly like to thank the publication managers and the Assistant Editor who were following up my article. I would also like to thank you for adjusting the money I paid initially into payment for my modified article,and refunding the balance.
I wish all success to your journal and look forward to sending you any suitable similar article in future"



Dr Mohan Z Mani,
Professor & Head,
Department of Dermatolgy,
Believers Church Medical College,
Thiruvalla, Kerala
On Sep 2018




Prof. Somashekhar Nimbalkar

"Over the last few years, we have published our research regularly in Journal of Clinical and Diagnostic Research. Having published in more than 20 high impact journals over the last five years including several high impact ones and reviewing articles for even more journals across my fields of interest, we value our published work in JCDR for their high standards in publishing scientific articles. The ease of submission, the rapid reviews in under a month, the high quality of their reviewers and keen attention to the final process of proofs and publication, ensure that there are no mistakes in the final article. We have been asked clarifications on several occasions and have been happy to provide them and it exemplifies the commitment to quality of the team at JCDR."



Prof. Somashekhar Nimbalkar
Head, Department of Pediatrics, Pramukhswami Medical College, Karamsad
Chairman, Research Group, Charutar Arogya Mandal, Karamsad
National Joint Coordinator - Advanced IAP NNF NRP Program
Ex-Member, Governing Body, National Neonatology Forum, New Delhi
Ex-President - National Neonatology Forum Gujarat State Chapter
Department of Pediatrics, Pramukhswami Medical College, Karamsad, Anand, Gujarat.
On Sep 2018




Dr. Kalyani R

"Journal of Clinical and Diagnostic Research is at present a well-known Indian originated scientific journal which started with a humble beginning. I have been associated with this journal since many years. I appreciate the Editor, Dr. Hemant Jain, for his constant effort in bringing up this journal to the present status right from the scratch. The journal is multidisciplinary. It encourages in publishing the scientific articles from postgraduates and also the beginners who start their career. At the same time the journal also caters for the high quality articles from specialty and super-specialty researchers. Hence it provides a platform for the scientist and researchers to publish. The other aspect of it is, the readers get the information regarding the most recent developments in science which can be used for teaching, research, treating patients and to some extent take preventive measures against certain diseases. The journal is contributing immensely to the society at national and international level."



Dr Kalyani R
Professor and Head
Department of Pathology
Sri Devaraj Urs Medical College
Sri Devaraj Urs Academy of Higher Education and Research , Kolar, Karnataka
On Sep 2018




Dr. Saumya Navit

"As a peer-reviewed journal, the Journal of Clinical and Diagnostic Research provides an opportunity to researchers, scientists and budding professionals to explore the developments in the field of medicine and dentistry and their varied specialities, thus extending our view on biological diversities of living species in relation to medicine.
‘Knowledge is treasure of a wise man.’ The free access of this journal provides an immense scope of learning for the both the old and the young in field of medicine and dentistry as well. The multidisciplinary nature of the journal makes it a better platform to absorb all that is being researched and developed. The publication process is systematic and professional. Online submission, publication and peer reviewing makes it a user-friendly journal.
As an experienced dentist and an academician, I proudly recommend this journal to the dental fraternity as a good quality open access platform for rapid communication of their cutting-edge research progress and discovery.
I wish JCDR a great success and I hope that journal will soar higher with the passing time."



Dr Saumya Navit
Professor and Head
Department of Pediatric Dentistry
Saraswati Dental College
Lucknow
On Sep 2018




Dr. Arunava Biswas

"My sincere attachment with JCDR as an author as well as reviewer is a learning experience . Their systematic approach in publication of article in various categories is really praiseworthy.
Their prompt and timely response to review's query and the manner in which they have set the reviewing process helps in extracting the best possible scientific writings for publication.
It's a honour and pride to be a part of the JCDR team. My very best wishes to JCDR and hope it will sparkle up above the sky as a high indexed journal in near future."



Dr. Arunava Biswas
MD, DM (Clinical Pharmacology)
Assistant Professor
Department of Pharmacology
Calcutta National Medical College & Hospital , Kolkata




Dr. C.S. Ramesh Babu
" Journal of Clinical and Diagnostic Research (JCDR) is a multi-specialty medical and dental journal publishing high quality research articles in almost all branches of medicine. The quality of printing of figures and tables is excellent and comparable to any International journal. An added advantage is nominal publication charges and monthly issue of the journal and more chances of an article being accepted for publication. Moreover being a multi-specialty journal an article concerning a particular specialty has a wider reach of readers of other related specialties also. As an author and reviewer for several years I find this Journal most suitable and highly recommend this Journal."
Best regards,
C.S. Ramesh Babu,
Associate Professor of Anatomy,
Muzaffarnagar Medical College,
Muzaffarnagar.
On Aug 2018




Dr. Arundhathi. S
"Journal of Clinical and Diagnostic Research (JCDR) is a reputed peer reviewed journal and is constantly involved in publishing high quality research articles related to medicine. Its been a great pleasure to be associated with this esteemed journal as a reviewer and as an author for a couple of years. The editorial board consists of many dedicated and reputed experts as its members and they are doing an appreciable work in guiding budding researchers. JCDR is doing a commendable job in scientific research by promoting excellent quality research & review articles and case reports & series. The reviewers provide appropriate suggestions that improve the quality of articles. I strongly recommend my fraternity to encourage JCDR by contributing their valuable research work in this widely accepted, user friendly journal. I hope my collaboration with JCDR will continue for a long time".



Dr. Arundhathi. S
MBBS, MD (Pathology),
Sanjay Gandhi institute of trauma and orthopedics,
Bengaluru.
On Aug 2018




Dr. Mamta Gupta,
"It gives me great pleasure to be associated with JCDR, since last 2-3 years. Since then I have authored, co-authored and reviewed about 25 articles in JCDR. I thank JCDR for giving me an opportunity to improve my own skills as an author and a reviewer.
It 's a multispecialty journal, publishing high quality articles. It gives a platform to the authors to publish their research work which can be available for everyone across the globe to read. The best thing about JCDR is that the full articles of all medical specialties are available as pdf/html for reading free of cost or without institutional subscription, which is not there for other journals. For those who have problem in writing manuscript or do statistical work, JCDR comes for their rescue.
The journal has a monthly publication and the articles are published quite fast. In time compared to other journals. The on-line first publication is also a great advantage and facility to review one's own articles before going to print. The response to any query and permission if required, is quite fast; this is quite commendable. I have a very good experience about seeking quick permission for quoting a photograph (Fig.) from a JCDR article for my chapter authored in an E book. I never thought it would be so easy. No hassles.
Reviewing articles is no less a pain staking process and requires in depth perception, knowledge about the topic for review. It requires time and concentration, yet I enjoy doing it. The JCDR website especially for the reviewers is quite user friendly. My suggestions for improving the journal is, more strict review process, so that only high quality articles are published. I find a a good number of articles in Obst. Gynae, hence, a new journal for this specialty titled JCDR-OG can be started. May be a bimonthly or quarterly publication to begin with. Only selected articles should find a place in it.
An yearly reward for the best article authored can also incentivize the authors. Though the process of finding the best article will be not be very easy. I do not know how reviewing process can be improved. If an article is being reviewed by two reviewers, then opinion of one can be communicated to the other or the final opinion of the editor can be communicated to the reviewer if requested for. This will help one’s reviewing skills.
My best wishes to Dr. Hemant Jain and all the editorial staff of JCDR for their untiring efforts to bring out this journal. I strongly recommend medical fraternity to publish their valuable research work in this esteemed journal, JCDR".



Dr. Mamta Gupta
Consultant
(Ex HOD Obs &Gynae, Hindu Rao Hospital and associated NDMC Medical College, Delhi)
Aug 2018




Dr. Rajendra Kumar Ghritlaharey

"I wish to thank Dr. Hemant Jain, Editor-in-Chief Journal of Clinical and Diagnostic Research (JCDR), for asking me to write up few words.
Writing is the representation of language in a textual medium i e; into the words and sentences on paper. Quality medical manuscript writing in particular, demands not only a high-quality research, but also requires accurate and concise communication of findings and conclusions, with adherence to particular journal guidelines. In medical field whether working in teaching, private, or in corporate institution, everyone wants to excel in his / her own field and get recognised by making manuscripts publication.


Authors are the souls of any journal, and deserve much respect. To publish a journal manuscripts are needed from authors. Authors have a great responsibility for producing facts of their work in terms of number and results truthfully and an individual honesty is expected from authors in this regards. Both ways its true "No authors-No manuscripts-No journals" and "No journals–No manuscripts–No authors". Reviewing a manuscript is also a very responsible and important task of any peer-reviewed journal and to be taken seriously. It needs knowledge on the subject, sincerity, honesty and determination. Although the process of reviewing a manuscript is a time consuming task butit is expected to give one's best remarks within the time frame of the journal.
Salient features of the JCDR: It is a biomedical, multidisciplinary (including all medical and dental specialities), e-journal, with wide scope and extensive author support. At the same time, a free text of manuscript is available in HTML and PDF format. There is fast growing authorship and readership with JCDR as this can be judged by the number of articles published in it i e; in Feb 2007 of its first issue, it contained 5 articles only, and now in its recent volume published in April 2011, it contained 67 manuscripts. This e-journal is fulfilling the commitments and objectives sincerely, (as stated by Editor-in-chief in his preface to first edition) i e; to encourage physicians through the internet, especially from the developing countries who witness a spectrum of disease and acquire a wealth of knowledge to publish their experiences to benefit the medical community in patients care. I also feel that many of us have work of substance, newer ideas, adequate clinical materials but poor in medical writing and hesitation to submit the work and need help. JCDR provides authors help in this regards.
Timely publication of journal: Publication of manuscripts and bringing out the issue in time is one of the positive aspects of JCDR and is possible with strong support team in terms of peer reviewers, proof reading, language check, computer operators, etc. This is one of the great reasons for authors to submit their work with JCDR. Another best part of JCDR is "Online first Publications" facilities available for the authors. This facility not only provides the prompt publications of the manuscripts but at the same time also early availability of the manuscripts for the readers.
Indexation and online availability: Indexation transforms the journal in some sense from its local ownership to the worldwide professional community and to the public.JCDR is indexed with Embase & EMbiology, Google Scholar, Index Copernicus, Chemical Abstracts Service, Journal seek Database, Indian Science Abstracts, to name few of them. Manuscriptspublished in JCDR are available on major search engines ie; google, yahoo, msn.
In the era of fast growing newer technologies, and in computer and internet friendly environment the manuscripts preparation, submission, review, revision, etc and all can be done and checked with a click from all corer of the world, at any time. Of course there is always a scope for improvement in every field and none is perfect. To progress, one needs to identify the areas of one's weakness and to strengthen them.
It is well said that "happy beginning is half done" and it fits perfectly with JCDR. It has grown considerably and I feel it has already grown up from its infancy to adolescence, achieving the status of standard online e-journal form Indian continent since its inception in Feb 2007. This had been made possible due to the efforts and the hard work put in it. The way the JCDR is improving with every new volume, with good quality original manuscripts, makes it a quality journal for readers. I must thank and congratulate Dr Hemant Jain, Editor-in-Chief JCDR and his team for their sincere efforts, dedication, and determination for making JCDR a fast growing journal.
Every one of us: authors, reviewers, editors, and publisher are responsible for enhancing the stature of the journal. I wish for a great success for JCDR."



Thanking you
With sincere regards
Dr. Rajendra Kumar Ghritlaharey, M.S., M. Ch., FAIS
Associate Professor,
Department of Paediatric Surgery, Gandhi Medical College & Associated
Kamla Nehru & Hamidia Hospitals Bhopal, Madhya Pradesh 462 001 (India)
E-mail: drrajendrak1@rediffmail.com
On May 11,2011




Dr. Shankar P.R.

"On looking back through my Gmail archives after being requested by the journal to write a short editorial about my experiences of publishing with the Journal of Clinical and Diagnostic Research (JCDR), I came across an e-mail from Dr. Hemant Jain, Editor, in March 2007, which introduced the new electronic journal. The main features of the journal which were outlined in the e-mail were extensive author support, cash rewards, the peer review process, and other salient features of the journal.
Over a span of over four years, we (I and my colleagues) have published around 25 articles in the journal. In this editorial, I plan to briefly discuss my experiences of publishing with JCDR and the strengths of the journal and to finally address the areas for improvement.
My experiences of publishing with JCDR: Overall, my experiences of publishing withJCDR have been positive. The best point about the journal is that it responds to queries from the author. This may seem to be simple and not too much to ask for, but unfortunately, many journals in the subcontinent and from many developing countries do not respond or they respond with a long delay to the queries from the authors 1. The reasons could be many, including lack of optimal secretarial and other support. Another problem with many journals is the slowness of the review process. Editorial processing and peer review can take anywhere between a year to two years with some journals. Also, some journals do not keep the contributors informed about the progress of the review process. Due to the long review process, the articles can lose their relevance and topicality. A major benefit with JCDR is the timeliness and promptness of its response. In Dr Jain's e-mail which was sent to me in 2007, before the introduction of the Pre-publishing system, he had stated that he had received my submission and that he would get back to me within seven days and he did!
Most of the manuscripts are published within 3 to 4 months of their submission if they are found to be suitable after the review process. JCDR is published bimonthly and the accepted articles were usually published in the next issue. Recently, due to the increased volume of the submissions, the review process has become slower and it ?? Section can take from 4 to 6 months for the articles to be reviewed. The journal has an extensive author support system and it has recently introduced a paid expedited review process. The journal also mentions the average time for processing the manuscript under different submission systems - regular submission and expedited review.
Strengths of the journal: The journal has an online first facility in which the accepted manuscripts may be published on the website before being included in a regular issue of the journal. This cuts down the time between their acceptance and the publication. The journal is indexed in many databases, though not in PubMed. The editorial board should now take steps to index the journal in PubMed. The journal has a system of notifying readers through e-mail when a new issue is released. Also, the articles are available in both the HTML and the PDF formats. I especially like the new and colorful page format of the journal. Also, the access statistics of the articles are available. The prepublication and the manuscript tracking system are also helpful for the authors.
Areas for improvement: In certain cases, I felt that the peer review process of the manuscripts was not up to international standards and that it should be strengthened. Also, the number of manuscripts in an issue is high and it may be difficult for readers to go through all of them. The journal can consider tightening of the peer review process and increasing the quality standards for the acceptance of the manuscripts. I faced occasional problems with the online manuscript submission (Pre-publishing) system, which have to be addressed.
Overall, the publishing process with JCDR has been smooth, quick and relatively hassle free and I can recommend other authors to consider the journal as an outlet for their work."



Dr. P. Ravi Shankar
KIST Medical College, P.O. Box 14142, Kathmandu, Nepal.
E-mail: ravi.dr.shankar@gmail.com
On April 2011
Anuradha

Dear team JCDR, I would like to thank you for the very professional and polite service provided by everyone at JCDR. While i have been in the field of writing and editing for sometime, this has been my first attempt in publishing a scientific paper.Thank you for hand-holding me through the process.


Dr. Anuradha
E-mail: anuradha2nittur@gmail.com
On Jan 2020

Important Notice

Original article / research
Year : 2023 | Month : July | Volume : 17 | Issue : 7 | Page : QC08 - QC14 Full Version

Acceptability, Safety and Compliance of Copper T 380A as a Postpartum Intrauterine Contraceptive Device Inserted via Vaginal or Intracaesarean Route: A Cohort Study


Published: July 1, 2023 | DOI: https://doi.org/10.7860/JCDR/2023/62441.18211
Animesh Naskar, Sukumar Saren, Monimala Murmu, Suchita Mandal, Abantika Ghosh, Rup Kamal Das

1. Associate Professor, Department of Obstetrics and Gynaecology, Sarat Chandra Chattopadhyay Government Medical College and Hospital, Uluberia, Howrah, West Bengal, India. 2. Medical Officer, Department of Obstetrics and Gynaecology, R.G. Kar Medical College and Hospital, Kolkata, West Bengal, India. 3. Assistant Professor, Department of Obstetrics and Gynaecology, R.G. Kar Medical College and Hospital, Kolkata, West Bengal, India. 4. Junior Resident, Department of Obstetrics and Gynaecology, R.G. Kar Medical College and Hospital, Kolkata, West Bengal, India. 5. Junior Resident, Department of Obstetrics and Gynaecology, R.G. Kar Medical College and Hospital, Kolkata, West Bengal, India. 6. Ex-Professor, Department of Obstetrics and Gynaecology, R.G. Kar Medical College and Hospital, Kolkata, West Bengal, India.

Correspondence Address :
Dr. Animesh Naskar,
Krishna Bihar, 10, Baje Shibpur 2nd Bye Lane, Shibpur, Howrah-711102, West Bengal, India.
E-mail: animesh282@gmail.com

Abstract

Introduction: Considering the high unmet need for family planning in India, especially in postpartum mothers, there is a necessity for reliable, long-term, highly efficacious, safe and reversible contraception like Intrauterine Device (IUD) in these women. Copper T 380A (CuT 380A) as a Postpartum Intrauterine Contraceptive Device (PPIUCD) can reduce maternal and perinatal mortality by decreasing unintended and closely spaced pregnancies in the postpartum period. Despite many advantages, the acceptability and utilisation of PPIUCD still remain very low due to lack of information about it.

Aim: To determine the acceptance, safety, and efficacy of Copper T 380A; its association with socio-demographic factors and to compare the clinical outcomes between vaginal and intracaesarean insertions of this device.

Materials and Methods: A hospital-based prospective cohort study was conducted in the Department of Obstetrics and Gynaecology, RG Kar Medical College and Hospital, Kolkata, India, from February 2021 to July 2021 among the cohort of 210 consecutive eligible postpartum mothers delivered either vaginally or by caesarean section. Primarily, acceptance rate was assessed. Postinsertion follow-up was done till six months after delivery to note various clinical outcomes and complications measuring safety of the device in terms of cramping pain abdomen, irregular vaginal bleeding, abnormal vaginal discharge, string problems, and perforation; compliance in terms of pregnancy and expulsion; and continuation of the device. All the follow-up results were compared between two modes of insertions. Comparison between categorical variables was done by Chi-square test.

Results: Out of 210 counselled mothers, Copper T 380A insertions were done in 178 (84.8%) postpartum mothers. The acceptance rate was slightly higher in intracaesarean group (n=87, 85.3%). The mean±Standard Deviation (SD) age of acceptance of IUCD in partcipants was 25.62±4.09 years with the highest rate observed in the age group of 21-25 years (n=98, 46.7%). Acceptance of the device was significantly associated with multipara and the clients completed primary education (p-value <0.05). On follow-up, overall complications are low. No case of perforation was reported. Significantly higher incidences of abnormal vaginal bleeding, foul smelling vaginal discharge, string problems, and expulsions were observed in the vaginal group (p-value <0.05). Pregnancy was recorded in five (5.5%) clients and all of them were in the vaginal group. Out of 178 acceptors, compliance-continuation of the device was shown by 151 (84.8%), with significantly higher in the caesarean group (p-value <0.000051). A significantly higher continuation rate was observed among the clients of low socio-economic status (p-value <0.000207). Abdominal pain (33.33%) was reported to be the most common reason for discontinuation of Copper T 380A.

Conclusion: Regardless of the mode of delivery, Copper T 380A is quite an acceptable, safe, effective, and convenient contraceptive method with a good continuation rate in the immediate postpartum period.

Keywords

Descended strings, Expulsion, Intrauterine device, Perforation, Vaginal insertion

Worldwide, one of the most important public health concerns is to deal with the high unmet need for contraception among the postpartum mothers in low and middle-income countries (1),(2). In India, 65% of women have an unmet need for family planning in their first year of postpartum period, but only 26% of women are adopting any method of family planning during this crucial time (3).

As per the Fifth round of the National Family Health Survey (NFHS-5), an Indian counterpart for the Demographic Health Survey (4), acceptance of PPIUCD is rising and there is a decreasing trend in unmet need across the country, despite having a miserable contribution of intrauterine devices of just 2.1%, among all the available methods of contraception practiced for family planning in India (4). Moreover, IUCD services are safe, effective and reversible, offered free of cost at all government facilities, and provide effective protection for 10 years with a very low failure rate of (<0.5 hundred woman years) (4). The under-utilisation of IUCD services is mainly due to the lack of knowledge, myths, and various misconceptions that prevailed both on the part of clients and service providers, which has resulted even in its discontinuation (3).

The World Health Organisation (WHO) recommends an interval between the last live birth and the next pregnancy of at least 24 months, a birth interval of 33 months to diminish detrimental maternal outcomes (5). Evidence shows that shorter inter-pregnancy interval (less than 18 months) rises the risk of adverse perinatal outcomes (6). Because of the high unmet need for family planning, the postpartum period is highly vulnerable of having unplanned pregnancy which causes unfavourable outcomes like abortion, premature labour, low birth weight baby, foetal loss, Postpartum Haemorrhage (PPH), and maternal death (7),(8). This behests effective and reliable long-term contraception in the postpartum period. PPIUCD is the only family planning method that is extremely effective, reliable, inexpensive, immediately reversible, non hormonal, and long-acting contraceptive that can be introduced during the immediate postpartum period and it has no negative effect on breastfeeding (7),(8),(9). When it is introduced after delivery, the PPIUCD has proved that, it can improve maternal and neonatal health by preventing adverse obstetric outcomes such as maternal and neonatal mortality and other health hazards associated with closely spaced pregnancies (10). Moreover, women are highly motivated and receptive in the postpartum period, and the need for additional hospital visits is minimal (11). Thus, postpartum family planning services must have to be emphasised, so that the mother can leave the healthcare facility with an effective contraceptive in place.

In numerous settings, evidence of the safety and feasibility of PPIUCD insertion has been systematically reviewed in the Cochrane database which concluded that the quality of evidence was moderate and future trials are necessary to estimate expulsion rates and side-effects of PPIUCD (12). However, most of the previous studies reported that the expulsion rate was high (13),(14),(15). Immediate postpartum Copper T 380A insertion is associated with lower expulsion rates than delayed postpartum insertion. Moreover, post-placental placement during caesarean section has lower expulsion rates than that of vaginal insertions (16).

So many advancements have been attempted to raise the acceptance rate and to reduce the expulsion rate. There might have some variations of outcomes at follow-up when PPIUCD was inserted through the vaginal route or intracaesarean. Comparative study results between vaginal and caesarean insertions are sparse. So far in India, limited researches have been conducted about the safety, efficacy, and follow-up data on adverse outcomes among the acceptors of PPIUCD (17),(18),(19),(20). Moreover, there are gaps in available pieces of literature regarding the insertion of PPIUCD between vaginal and intracaesarean routes, which may have different outcomes on follow-up. So, with this background, the present study aimed to evaluate the outcome, complications, and continuation rate of Copper T 380A insertion and to compare outcomes of vaginal and intracaesarean insertions of it in a tertiary care teaching hospital in India.

Material and Methods

It was a hospital-based prospective cohort study conducted in the Department of Obstetrics and Gynaecology, R.G. Kar Medical College and Hospital, Kolkata, India, from February 2021 to July 2021, among the 210 consecutive eligible postpartum mothers, who attended either an antenatal clinic or were admitted to labour ward and delivered in the study Institution. The study was carried out after obtaining the Ethical clearance for the study protocol from the Institutional Ethics Committee (vide memo No. RKC/124 dated 12.02.2020). Just prior to the insertion of the IUD, written informed consent was taken only from those eligible mothers, who accepted the device.

Inclusion criteria: Mothers having age ≤35 years, gestational age 34-40 weeks, anticipate Vaginal Delivery (VD) or caesarean section, no infection, willing to follow-up, meeting all eligibility criteria of postpartum IUCD insertion, willing to have CuT 380A after counselling.

Exclusion criteria: Those having uterine anomalies and distorted uterine cavity (septate uterus, bicornuate uterus, fibroid uterus etc.,), known active case of sexually transmitted disease, multiple partners, known case of bleeding diathesis, unresolved PPH, chorioamnionitis and rupture of membranes more than 18 hours, suffering from an immunosuppressive disease {e.g., Acquired Immunodeficiency Syndrom (AIDS)}, known case to copper allergy, haemoglobin less than 7 gm% and extensive genital trauma.

Sample size calculation: The sample size was calculated based on a study conducted on the Indian population which showed that as a reversible method of contraception, the acceptance rate of PPIUCD was 67.12% among the acceptors (21). Considering 95% confidence interval, (Z1-α/2)=Standard normal deviation had a value 9of 1.96, the authors used the formula to calculate the sample size as, N=(Z1-α/2)2×Q×P/L2.

N=Sample size
P=Expected proportion of cases mentioning the reason for accepting PPIUD as 67.12% (reversible method).
Q=(100-P)
L=Precision in absolute term i.e., 6.71

So, N=(1.96)2×(100-67.12)×67.12/6.712

=8474.51/45.02
=188.23

Taking lost to follow-up cases into account, 10% more cases were added to estimate sample size. So, the sample size was, N=188.23+18.82=207.05, in round figure it was 210. Considering the short period of observation to be only six months, only a small portion of these patients could be included by convenience sampling.

Study Procedure

A predesigned pretested proforma, bed head tickets, antenatal cards, medical records, investigation reports etc., were used as a study tool. Details regarding the socio-demographic factors like age, education, occupation, Socio-economic Status (SES) (22), religion, residence and obstetric history i.e., parity, the timing of PPIUCD insertion, client perception of pain during and after PPIUCD insertion and duration of last childbirth, as well as, data from the follow-up visits i.e., compliance of PPIUCD, side-effects, the reason for removal and satisfaction were recorded in proforma sheet.

The CuT 380A used in the present study was available free of cost in the study institution as PPIUCD services became a Government of India program in 2010. The device was inserted either post-placental (within 10 minutes of placental delivery); postpartum (within 48 hours of delivery) or intracaesarean. The IUCD was placed in the uterine fundus with the help of Kelly’s placental forceps by trained doctors only, during vaginal insertion either post-placental or postpartum period under sterile conditions. For intracaesarean insertion, IUCD was held between the middle finger and index finger of the surgeon’s hand after passing it through the lower uterine incision and placed at the uterine fundus followed by the withdrawal of the hand, taking care of the IUCD remains in the proper place and subsequently lower segment incision was closed. Records were maintained regarding PPIUCD insertions and services by the provider. Postinsertion counselling was done and patients were advised to follow-up routinely for examination at the postpartum unit of the present study center as Outpatient Department (OPD) basis after six weeks, three months, and at six months postdelivery to assess complications, expulsion and failure rate of this device.

During the follow-up visit, the women were asked, if they had any complaints, and a physical and pelvic examination was carried out to assess uterine subinvolution and suprapubic tenderness, and ultrasonography was performed, if necessary to assess the IUCD strings have descended into the vagina or in cases of missing string, the authors checked the expulsion and confirm the presence of intrauterine IUCD. Descended strings were trimmed 3 cm beyond the external os. For any medical or personal reason, if the mother requested for removal of IUCD, she was counselled and the device was removed. In case of removals or expulsions, the women were offered reinsertion of IUCD or alternative contraceptive measures. Findings of the follow-up visit within six weeks, after three months, and after six months of delivery were recorded for all clients. Follow-up findings like abdominal or pelvic pain, vaginal bleeding, infection, fever, spontaneous expulsion, abnormal vaginal discharge, perforation, long string, missing string, other side-effects and symptoms of pregnancy, or willingness to continue or not were recorded. In case, women failed to return for follow-up, they were contacted over the telephone.

The primary outcome measure was the acceptability of PPIUCD among various socio-demographic variables in the present study study participants. The secondary outcome measures were the clinical parameters in terms of safety (abnormal foul smelling vaginal discharge, infection, irregular and heavy bleeding, pelvic pain, perforation), IUCD string problems, pregnancy or failure, expulsion and continuation compliance. These outcome measures were compared between intracaesarean and vaginal insertions of PPIUCD.

Statistical Analysis

Statistical analysis was done by Statistical Package for the Social Sciences (SPSS) software version 27.0 (SPSS Inc., Chicago, IL, USA) and GraphPad Prism version 5. Data had been summarised as the mean and, standard deviation for numerical variables and count and percentages for categorical variables. A Chi-square test (χ2 test) was used for comparison between categorical variables. A p-value of ≤0.05 was considered statistically significant.

Results

A total of 210 study participants, with a mean age of 25.62±4.09 years, were counselled for Copper T 380A insertion during their antenatal visits in OPD and following their admission with early labour in labour room, and also in postpartum period. Most of the study population were in the age group of 21-25 years (n=98, 46.7%), multipara (n=141, 67.1%) and belonged to lower socio-economic class (n=176, 83.3%) (Table/Fig 1). Out of total study population, 102 (48.6%) patients underwent caesarean section and 108 (51.4%) women delivered vaginally.

Out of 210 study population, the number of PPIUCD acceptors was 178 (84.8%), whereas 32 (15.2%) clients declined insertion. The observed difference in the proportion of acceptors between intracaesarean and VD group was statistically insignificant (p-value=0.8347) (Table/Fig 2). Among the mothers who declined to insertion of device, majority were reported due to fear and concern of complications (34.37%), followed by husband or family refusal (21.87%) and religious belief (15.6%) (Table/Fig 3).

The mean age of acceptance of IUCD was 25.59±4.06 years with highest acceptance being in the age group of 21-25 years (n=82, 46.1%). The observed difference in acceptability of Copper T 380A between multipara (61.2%) and primipara (38.8%) was statistically significant (p-value <0.0001) (Table/Fig 4).

Of the total acceptance (n=178), only 11 (6.2%) mothers had heavy and prolonged vaginal bleeding. Among the acceptors, 4 (2.2%) patients had complete expulsion and 9 (5.1%) patients experienced partial expulsion of Copper T 380A. The compliance continuation rate was 84.8% (n=151) and failure rate was 2.8% (n=5) (Table/Fig 5).

The acceptors were followed-up to evaluate the complication at the 6th week, 3rd month and 6th month of insertion. Abdominal pain was the most common adverse event and noted in 67 (37.64%), 56 (31.4%), 54 (30.3%) mothers at 6th week, 3rd month and 6th month of follow-up, respectively. Highest incidence (n=13, 7.3%) of expulsion was recorded at 6th month of insertion (Table/Fig 6).

In the present study, a significantly higher incidence of excessive vaginal bleeding was reported in VD group than that of intracaesarean group (p-value=0.0064). In the present study, total five (5.5%) clients who had pregnancy or contraceptive failure belonged to VD cohort which was statistically significant (p-value=0.0265) (Table/Fig 7).

Association of mode of delivery with continuation compliance was statistically significant (p-value=0.000051). The current study indicated that highest continuation rate of use of Copper T 380A was observed among the acceptors who belonged to lower socio-economic status (n=133, 86.8%). Association of socio-economic status with compliance-continuation of IUCD use was found to be statistically significant (p-value=0.000207) (Table/Fig 8).

(Table/Fig 9) depicted the most common reasons to discontinue the method. These were cramping pain abdomen (n=9, 33.33%); followed by irregular excessive bleeding per vaginal in 6 (22.22%) patients; objection from husband and in-laws was experienced by 3 (11.11%) participants. Of all, 5 (18.57%) participants requested discontinuation of the method following expulsion of the device.

Discussion

The mean age of the present study population is almost comparable to the study participants in the study by Gonie A et al., and Divakar H et al., where the mean age of study participants was 26.26±4.78 years and 24.5±4.295 years, respectively (10),(23). Out of 210 participants, largest proportion of women were in the age group of 21-25 years (46.7%), multigravida (67.1%), and belonged to lower socio-economic status (83.8%). This demographic profile is almost similar to a study done by Gonie A et al., (10). In a recent study conducted in Delhi, revealed majority (78.6%) of participants belonged to the age group of 20-30 years, with 79.2% having education of Class X and above, 70.9% of the women were from urban sector and 73% belonged to upper or upper middle class (24). A high rate of acceptance (84.8%) of PPIUCD in the present study, was in concordance with the studies by Chattopadhyay S et al., and Kant S et al., but in discordance to other studies (10),(25),(26),(27).

Difference in the educational level of participants, awareness, misconceptions, and religious faiths about PPIUCD insertion might be the cause for the differences (10). Availability of trained healthcare workers with improved counselling skills in antenatal clinic in the present study institute, made it possible for higher acceptance of Copper T 380A in current study as compared to the previous published literature (15),(28),(29). There was comparable proportion of study participants in both VD and caesarean section group (n=108, 51.4% and n=102, 48.6% respectively) in present study but the acceptance rate among caesarean section cohort (n=87, 85.3%) was slightly higher than that of VD group (n=91, 84.3%) which is similar to other studies [17,19,26,28]. Postcaesarean conception fear might be the reason for higher acceptance of the PPIUCD among the caesarean insertion cohort. Most common perceived reasons of non acceptability of the copper device use reported by the participants were fear and concerns of complications (34.37%), followed by husband or family refusal (21.87%) and religious belief (15.6%). These observations of the present study were supported by other studies conducted in India and abroad (10),(21),(25).

In the present study, highest acceptance among women of 21-25 years (46.7%) which was comparable to that of other studies (15),(29). Significant proportion of acceptors in the current study, were multipara (61.2%) which is supported by published literatures (30),(31). Some recent studies also reported that most of the acceptors of PPIUCD were delivering for the second time (10),(27),(32). In contrast to othe present study, a higher acceptance among primipara was reported in several previous studies (15),(19),(28).

Level of education plays a vital role in motivating and creating a positive attitude of clients towards the use of PPIUCD which was reflected in the current study where a significant proportion of acceptability (p-value <0.0001) of IUCD device was reported among women who completed the primary and secondary level of education, which was similar to other studies (21),(25). The majority of women were primary school educated (39.2%), while 37.2% were illiterate in a study conducted by Bhadra B et al., (32). Although socio-economic status and religion did not appear to be significantly related to acceptance of PPIUD insertion in the present study (p-value was 0.8274 and 0.0810, respectively), there was high acceptability among lower socio-economic class (83.1%) and among the Muslim acceptors (58.4%). This was concurrent with a study conducted in North India by Kant S et al., that revealed a higher acceptance rate (48.6%) of IUCD among poorer families as compared to those from richer ones (26.1%) and higher acceptability of the method (70.6%) among women belonging to Muslim religion (26). Higher acceptance was also reported in the clients of lower SES in a study done by Agarwal N et al., (20). The reason might be that acceptors of higher economic families had better knowledge and access to other alternative methods such as injectable hormonal contraceptives and thereby, these women could have preferred contraceptive methods apart from PPIUCD. High acceptance of the method among women belonging to the Muslim religion could be explained by the fact that, if confidentiality, privacy, and adequate counselling could be provided to the Muslim clients, acceptability of PPIUCD would be higher as their Hindu fellows.

Sharma N et al., observed that irregular bleeding was the most common complaint (5.64% at 6th week and 3.07% in 6th month) on follow-up visits which was corroborative to current study findings (27). Menorrhagia was also noted by Hooda R et al., in 10.5% of women at their six weeks of postinsertion follow-up visit (17). On follow-up, the incidence of abnormal and offensive vaginal discharge (p-value=0.0003), was significant between two modes of insertions (vaginal and intracaesarean) of CuT 380A. Hooda R et al., reported unusual vaginal discharge in 12.3% women at follow-up and this was significantly higher after caesarean IUCD insertions (p-value=0.037) and there was no significant difference in rates of irregular bleeding between the two insertion groups, which was discordant to the present findings (17).

In a recent study, the observed difference was not statistically significant (p-value >0.05) when the complications were compared between the two groups of insertions (33). Higher incidence of bleeding per vaginal and pelvic pain was reported in vaginal insertions compared to intracaesarean insertions, but this difference was statistically not significant (p-value >0.05) (34). Shukla M et al., indicated a higher incidence of vaginal bleeding (27.2%) with use of CuT 200 in postpartum mothers (14).

Incidence of missing threads reported to be more common after caesarean insertion in comparison to vaginal group (4.3% vs. 2.7%), in a study conducted in Kalyani (32). This was in discordance to the present study, which reported significantly high rate of string problems in vaginal insertion group. In the present study, rate of expulsion of CuT 380A among vaginally delivered patients was appeared to be statistically higher (p-value=0.0107) in comparison to Caesarean group and this finding was similar to recent published literatures (17),(35), though overall incidence of expulsion (7.3%) in present study was lesser than other studies (35),(36). Expulsion rate of PPIUCD may differ due to variation in provider’s skill, and follow-up services of the device are essential to ensure its continuation as well as client’s satisfaction of this method (15). Lesser expulsion might be due to skilled insertion of all IUCDs by doctors only in our set-up and decreased expulsion rate after trans caesarean insertion as compared to vaginal insertion might be due to direct placement of device at the fundus during caesarean delivery.

No incidence of perforation of the uterus recorded during the procedure of insertion in both groups in the present study. Moreover on follow-up, failure of the procedure in terms of pregnancy was only 2.8% (n=5) and all the cases were in the VD group which was in accordance with a recent literature (25). However, further follow-up with longer duration is necessary. No cases of perforation also recorded in the study conducted by Bhadra B et al., (32). The study conducted by other researchers also reported no cases of perforation and pregnancy in their study (17),(33). Out of 52 followed-up acceptors, one case of intrauterine pregnancy was reported by Kanhere AV et al., (37).

In the present study, the rate of continuation of IUCD (84.8%) was much higher than a study conducted by Sarkar S et al., (38). Moreover, our finding was comparable to reports revealed in literatures which recorded continuation rate more than 80% [17,39,40]. Low continuation rate (42.6%) was also reported in another study conducted at Agartala (41). The difference of continuation rate might be explained by the fact that there are variations in the educational levels of acceptors, misconceptions, beliefs and adverse effects experienced by the users. Continuation of CuT 380A was significantly higher in caesarean section group (p-value=0.000051) in the present study which was similar to other recent studies (35),(42). Dedicated counselling in postinsertion period in addition to routine antenatal, intranatal and postnatal counselling among the acceptors might play a pivotal role for very high rate of continuation of copper device used by the lower socio-economic group in the present study. A recent Indian study revealed that there was decreased continuation of CuT 380A among women of higher parity and increased chances of continued use of IUCD with the higher educational levels among the acceptors (AOR: 1.63, CI: 1.10-2.41, p-value <0.01) (43). This was in contrast to othe present study finding. Discontinuation rate of IUCD was observed to be higher (15.16%) in present study in comparison to that of other studies, where discontinuation rate was 4.1% and 8.08% (17),(39).

Agrahari K et al., observed that the IUCD discontinuation rate was lower among the poorest and richest but higher in middle class and this finding was discordant to present study (44). The study conducted by Sharma M et al., revealed that discontinuation of IUCD inversely varied with the educational level of the women, with the highest discontinuation rate found in illiterate women (95%) and the lowest among graduates (53.6%) (45). The significant association between SES and continuation of IUCD might be explained by the fact that an improvement in educational status of women will certainly improve the awareness, knowledge and motivation for PPIUCD insertion.

Limitation(s)

As the present study was a facility-based single-centre study and had a short period of follow-up, the findings might not reflect the population as a whole. So, a study with larger sample size and long-term follow-up could sufficiently address the issues like incidence of rare complications like perforation and pregnancy rate in both groups of insertions.

Conclusion

Irrespective of the mode of insertion, Copper T 380A is a safe, convenient, and highly efficacious contraceptive intervention in the postpartum period with high acceptability and a good compliance-continuation rate. The device should be incentivised in both vaginal and caesarean deliveries as facility-based births have increased due to governmental boosts in overpopulated countries like India, where there is a high rate of unintended pregnancy in the postpartum period. Expulsion rate was minimal and no incidence of perforation was recorded. The benefits of the device outweigh the insignificant adverse effects of the IUCD. Moreover, these minor risks can be minimised by increasing technical expertisation of healthcare personnel, adequate counselling at every delivery set-up and early follow-up examination.

Acknowledgement

Authors acknowledge the Department of Gynaecology and Obstetrics of RG Kar Medical College and Hospital, Kolkata, India for providing Copper T 380A devices free of cost to all the study participants. The authors are also grateful to all the patients for their cooperation. The authors would like to thank all other colleagues and hospital staff for providing their expertisation, which immensely helped them to complete the present study work.

References

1.
World Health Organization, WH. Statement for collective action for postpartum family planning. 2012. https://www.mchip.net/sites/default/fles/PPFP%20Statement%20for%20Action.pdf.
2.
Cleland J, Shah IH, Daniele M. Interventions to improve postpartum family planning in low- and middle-income countries: Program implications and research priorities. Stud Fam Plan. 2015;46(4):423-41. https://doi.org/10.1111/j.1728-4465.2015.00041.x). [crossref][PubMed]
3.
Postpartum IUCD Reference Manual for Medical Officers and Nursing Personnel, September 2013, Family Planning Division, Ministry of Health and Family Welfare, Govt. of India5.WHO.
4.
International Institute for Population Sciences (IIPS) and ICF. 2021. National Family Health Survey (NFHS-5), 2019-21, India: Volume I. http://www.rchiips.org/nfhs or http://www.iipsindia.ac.in.
5.
Report of a WHO Technical Consultation on Birth Spacing. 2007; WHO/RHR/07.1 https://apps.who.int/iris/handle/10665/69855.
6.
Jena BH, Biks GA, Gete YK, Gelaye KA. Effects of inter-pregnancy intervals on preterm birth, low birth weight and perinatal deaths in urban South Ethiopia: A prospective cohort study. Matern Health, Neonatol and Perinatol. 2022;8:3. https://doi.org/10.1186/s40748-022-00138-w. [crossref][PubMed]
7.
WHO. Programming Strategies for Postpartum Family Planning; World Health Organization. Geneva: WHO Libr Cat Data; 2013. ISBN 978 9.
8.
Hounton S, Winfrey W, Barros AJ, Askew I. Patterns and trends of postpartum family planning in Ethiopia, Malawi, and Nigeria: Evidence of missed opportunities for integration. Glob Heal Action. 2015;8:29738. https://doi.org/103402/gha.v829738. [crossref][PubMed]
9.
Jhpiego Corporation. Postpartum Intrauterine Contraceptive Device (PPIUD) Services; A Reference Manual for Providers. Balt Maryl 21231-3492, USA. ACCESS Family Planning Initiative, USIAD. 2010. https://www.glowm.com/pdf/Global%20PPIUD%20Reference 20Manual.pdf.
10.
Gonie A, Worku C, Assefa T, Bogale D, Girma A. Acceptability and factors associated with postpartum IUCD use among women who gave birth at bale zone health facilities. Contracept Reprod Med. 2018;3:16. https://doi.org/10.1186/s40834-018-0071-z. [crossref][PubMed]
11.
Iftikhar PM, Shaheen N, Arora E. Efficacy and satisfaction rate in postpartum intrauterine contraceptive device insertion: A prospective study. Cureus. 2019;11(9):e5646. [crossref]
12.
Lopez LM, Bernholc A, Hubacher D, Stuart G, Van Vliet HAAM. Immediate postpartum insertion of intrauterine device for contraception. Cochrane Database of Systematic Reviews. 2015;6:CD003036. Doi: 10.1002/14651858.CD003036.pub3. Accessed 12 September 2022. [crossref]
13.
Celen S¸ , Sucak A, Yildiz Y, Danis¸ man N. Immediate postplacental insertion of an intrauterine contraceptive device during cesarean section. Contraception. 2011;84(3):240-43. [crossref][PubMed]
14.
Shukla M, Qureshi S, Chandrawati. Post-placental intrauterine device insertion- A five year experience at a tertiary care centre in north India. Indian Journal of Medical Research. 2012;136(3):432-35.
15.
Mishra S. Evaluation of safety, efficacy, and expulsion of post-placental and intra-cesarean insertion of intrauterine contraceptive devices (PPIUCD). Journal of Obstetrics and Gynaecology of India. 2014;64(5):337-43. [crossref][PubMed]
16.
World Health Organization. Medical eligibility criteria for contraceptive use. Fifth edition 2015; Pp. 190. https://apps.who.int/iris/bitstream/handle/10665/18146 8/9789241549158.
17.
Hooda R, Mann S, Nanda S, Gupta A, More H, Bhutani J. Immediate postpartum intrauterine contraceptive device insertions in caesarean and vaginal deliveries: A comparative study of follow- up outcomes. Int J Reprod Med. 2016;2016:7695847. [crossref][PubMed]
18.
Yadav V, Balasubramaniam S, Das S, Srivastava A, Kumar S, Sood B. Comparison of outcomes at 6 weeks following postpartum intrauterine contraceptive device insertions by doctors and nurses in India: A case-control study. Contraception. 2016;93(4):347-55. [crossref][PubMed]
19.
Vidyarama R, Nagamani T, Prasad U. PPIUCD as a long acting reversible contraceptive (LARC)- an experience at a tertiary care centre. Interantional J Sci Res. 2015;4:03-05.
20.
Agarwal N, Gupta M, Agrawal A, Sharma A. Efficacy and safety of Postpartum Intrauterine Contraceptive device (PPIUCD) insertion-A prospective study. Santosh Univ J Heal Sci. 2017;3(1):20-23. [crossref]
21.
Jairaj S, Dayyala S. A cross-sectional study on acceptability and safety of IUCD among postpartum mothers at tertiary care hospital, Telangana. J Clin Diagn Res. 2016;10(1):LC01-LC4. Doi: 10.7860/JCDR/2016/16871.7020. [crossref][PubMed]
22.
Majumder S. Socioeconomic status scales: Revised Kuppuswamy, BG Prasad, and Udai Pareekh’s Scale updated for 2021. J Family Med Prim Care. 2021;10(11):3964-67. [crossref][PubMed]
23.
Divakar H, Bhardwaj A, Purandare CN, Sequeira T, Sanghvi P. Critical factors influencing the acceptability of post-placental insertion of intrauterine contraceptive device: A study in six public/private institutes in India. J Obstet Gynecol India. 2019;69(4):344-49. https://doi.org/10.1007/s13224-019-01221-7. [crossref][PubMed]
24.
Nigam A, Ahmad A, Sharma A, Saith P, Batra S. Postpartum intrauterine device refusal in Delhi: Reasons analyzed. J Obstet Gynecol India. 2018;68:208-13. https://doi.org/10.1007/s13224-015-0714-9. [crossref][PubMed]
25.
Chattopadhyay S, Bhattacharyya SK, Patra KK, Raj S, Mandal T. Evaluation of acceptability, safety, efficacy and outcome of postplacental IUCD insertion in women undergoing both vaginal delivery and caesarean section- a cohort study [Internet]. 2021 July [Cited July 29, 2022];10(3):SO23-SO26. Available from: http://www.jcdr.net//back_issues.asp?issn=0973-709x&year=2.
26.
Kant S, Archana S, Singh AK, Ahamed F, Haldar P. Acceptance rate, probability of follow-up, and expulsion of postpartum intrauterine contraceptive device offered at two primary health centers, North India. J Fam Med Prim Care. 2016;5:770-76.[crossref][PubMed]
27.
Sharma N, Gupta V, Sharma A. Review of PPIUCD at tertiary care centre in Southern Rajasthan. Asian J Med Sci [Internet]. 2021 Dec. 1 [cited 2022 Jul. 29];12(12):91-95. Available from: https://www.nepjol.info/index.php/AJMS/ article/view/39110021&month=July&volume=10&issue=3&page=SO23& d=2671. Doi: 10.7860/JCDR/2021/48033/2671. [crossref]
28.
Gautam R, Arya KN, Kharakwal S, Singh S, Trivedi M. Overview of immediate PPIUCD application in Bundelkhand region. J Evol Med Dent Sci. 2014;3(36):9518 26. [crossref]
29.
Katheit G, Agarwal J. Evaluation of Post placental Intrauterine Device (PPIUCD) in terms of awareness, acceptance, and expulsion in a tertiary care centre. Available from: http://www.ijrcog.org/?mno=44335. [Last cited on 2015 Jun 23].
30.
Goswami G, Yadav K, Patel A. A prospective study to evaluate safety, efficacy and expulsion rate of post placental insertion of intra uterine device. Journal of Evolution of Medical and Dental Sciences. 2015;4(56):9770-74. [crossref]
31.
Doley R, Pegu B. A retrospective study on acceptability and complications of PPIUCD insertion. J Evolution Med Dent Sci. 2016;5(31):1631-34. Doi: 10.14260/ jemds/2016/38. [crossref]
32.
Bhadra B, Burman SK, Purandare CN, Divakar H, Sequeira T, et al. The impact of using nurses to perform postpartum intrauterine device insertions in Kalyani Hospital, India. Int J Gynecol Obstet. 2018;143(Suppl. 1):33-37. [crossref][PubMed]
33.
Harani MK, Sarkar NC, Saha MM, Paul M, Debnath A. A prospective study on PPIUCD insertion between vaginal delivery and caesarean section. J Clin of Diagn Res. 2019;13(7):QC12-QC14. https://www.doi.org/10.7860/ JCDR/2019/41321/13013.
34.
Goyal A, Wadhwani R, Agarwal A, Pandey A. Comparative study of IUCD inserted intracesarean and after vaginal delivery. Int J Reprod Contracept Obstet Gynecol. 2018;7(5):2007-10. [crossref]
35.
Jadhav A, Patil A. A comparative study of post-placental IUCD insertion after vaginal delivery versus during caesarean section. MVP J Med Sci. 2020;7(2):151-54. [crossref]
36.
Najam M, Rasheed N, Aslam S. Immediate postpartum insertion of IUCD during Caesarean delivery and vaginal delivery. Postpartum intrauterine contraceptive device: Expulsion rate after vaginal delivery and caesarean section. JSZMC. 2018;9(1):1328-30.
37.
Kanhere AV, Pateriya P, Jain M. Acceptability and feasibility of immediate postpartum IUCD insertion in a tertiary care centre in central India. Int J Reprod Contracept Obstet Gynaecol. 2015;4(1):179-84. [crossref]
38.
Sarkar S, Paul DP, Ray J. A comparative evaluation of post placental intrauterine contraceptive device (IUCD) insertion between normal delivery and caesarean section. Int J Reprod Contracept Obstet Gynecol. 2018;7:3826-30. [crossref]
39.
Rana M, Atri SK, Chib V, Kumari N. Postpartum intrauterine contraception device, a method of contraception: A study from rural north India. Int J Clin Obstet Gynaecol. 2019;3(1):169-73. Doi: 10.33545/gynae.2019.v3.i1c.405. [crossref]
40.
Agrawal S, Induja R, Chopra K, Singh A, Sood S, Puri M. Study of the client experience and continuation rate of postpartum intrauterine Copper-T device in semi-urban population in India. Int J Adv Med Health Res. 2022;9:38-41. [crossref]
41.
Paul DP, Ray J, Sarkar S. Study of outcome of Intrauterine Contraceptive device (CuT-380A) insertion immediately after vaginal delivery[J]. AIMS Medical Science. 2020;7(4):328-36. Doi: 10.3934/medsci.2020022. [crossref]
42.
Agarwal R, Singh S. Evaluation of safety and efficacy of Postpartum Intrauterine Contraceptive Devices (PPIUCD) in vaginal and caesarean section deliveries: A hospital based study. MAMC J Med Sci. 2020;6(3):199-203. [crossref]
43.
Singal S, Sikdar SK, Kaushik S, Singh P, Bhatt N, Samandari G, et al. Understanding factors associated with continuation of intrauterine device use in Gujarat and Rajasthan, India: A cross-sectional household study. Sex Reprod Health Matters. 2021;29(2):01-16. Doi:10.1080/26410397.2021.1933815. [crossref][PubMed]
44.
Agrahari K, Mohanty SK, Chauhan RK. Socio-economic differentials in contraceptive discontinuation in India. SAGE Open. April 2016. Doi: 10.1177/ 2158244016646612s. [crossref]
45.
Sharma M, Joshi S, Nagar O, Sharma A. Determinants of intrauterine contraceptive device discontinuation among Indian women. J Obstet Gynaecol India. 2014;64(3):208-11. Doi: 10.1007/s13224-014-0516-5.[crossref][PubMed]

DOI and Others

DOI: 10.7860/JCDR/2023/62441.18211

Date of Submission: Dec 22, 2022
Date of Peer Review: Apr 14, 2023
Date of Acceptance: May 11, 2023
Date of Publishing: Jul 01, 2023

AUTHOR DECLARATION:
• Financial or Other Competing Interests: None
• Was Ethics Committee Approval obtained for this study? Yes
• Was informed consent obtained from the subjects involved in the study? Yes
• For any images presented appropriate consent has been obtained from the subjects. NA

PLAGIARISM CHECKING METHODS:
• Plagiarism X-checker: Dec 23, 2022
• Manual Googling: Apr 12, 2023
• iThenticate Software: May 10, 2023 (13%)

ETYMOLOGY: Author Origin

EMENDATIONS: 5

JCDR is now Monthly and more widely Indexed .
  • Emerging Sources Citation Index (Web of Science, thomsonreuters)
  • Index Copernicus ICV 2017: 134.54
  • Academic Search Complete Database
  • Directory of Open Access Journals (DOAJ)
  • Embase
  • EBSCOhost
  • Google Scholar
  • HINARI Access to Research in Health Programme
  • Indian Science Abstracts (ISA)
  • Journal seek Database
  • Google
  • Popline (reproductive health literature)
  • www.omnimedicalsearch.com